Search Results - "Gandy, Michael N"
-
1
The monoamine re-uptake inhibitor UWA-101 improves motor fluctuations in the MPTP-lesioned common marmoset
Published in PloS one (20-09-2012)“…The wearing-OFF phenomenon is a common motor complication of chronic L-3,4-dihydroxyphenylalanine (L-DOPA) therapy for Parkinson's disease. We recently…”
Get full text
Journal Article -
2
Synthesis of Kalasinamide, a Putative Plant Defense Phototoxin
Published in Journal of natural products (Washington, D.C.) (01-05-2008)“…The first total synthesis of the azaanthracene kalasinamide (1) is described, and the discrepancy in the reported 13C NMR data and melting points for the…”
Get full text
Journal Article -
3
An interactive database to explore herbicide physicochemical properties
Published in Organic & biomolecular chemistry (28-05-2015)“…Herbicides are an essential tool not only in weed management, but also in conservation tillage approaches to cropping. The first commercial herbicides were…”
Get more information
Journal Article -
4
Towards aryl C-N bond formation in dynamic thin films
Published in Organic & biomolecular chemistry (14-07-2014)“…C-N bond forming reactions are important in organic chemistry. A thin film microfluidic vortex fluidic device (VFD) operating under confined mode affords…”
Get more information
Journal Article -
5
A simple and robust preparation of N-acetylindoxyls: precursors for indigogenic substrates
Published in Organic & biomolecular chemistry (21-01-2015)“…A generalised, simple and efficient synthesis of N-acetyl-5-bromo-4-chloroindoxyl and related analogues required for the synthesis of indigogenic substrates to…”
Get more information
Journal Article -
6
A general method for affinity-based proteomic profiling of exo-α-glycosidases
Published in Chemical communications (Cambridge, England) (07-05-2011)“…Synthesis of iminosugar-based affinity-based proteomics probes for use in probing exo-α-glycosidase activity…”
Get more information
Journal Article -
7
A novel MDMA analogue, UWA‐101, that lacks psychoactivity and cytotoxicity, enhances l‐DOPA benefit in parkinsonian primates
Published in The FASEB journal (01-05-2012)“…Treatment of Parkinson's disease with dopaminergic agents, such as l‐DOPA, is frequently compromised by disabling side effects, particularly dyskinesia and a…”
Get full text
Journal Article -
8
Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine (‘ecstasy’) through iterative chemical redesign: mechanisms and pathways to cell death
Published in Investigational new drugs (01-08-2012)“…Summary While 3,4-methylenedioxymethamphetamine (MDMA/‘ecstasy’) is cytostatic towards lymphoma cells in vitro, the concentrations required militate against…”
Get full text
Journal Article -
9
Physical and crystallographic characterisation of the mGlu5 antagonist MTEP and its monohydrochloride
Published in Journal of pharmaceutical sciences (01-01-2010)“…An improved medium scale synthesis of 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP), a selective and potent metabotropic glutamate subtype 5 (mGlu5)…”
Get more information
Journal Article -
10
Enzymatic Metabolism of Ergosterol by Cytochrome P450scc to Biologically Active 17α,24-Dihydroxyergosterol
Published in Chemistry & biology (01-08-2005)“…We demonstrate the metabolism of ergosterol by cytochrome P450scc in either a reconstituted system or isolated adrenal mitochondria. The major reaction product…”
Get full text
Journal Article -
11
Enzymatic metabolism of ergosterol by cytochrome p450scc to biologically active 17alpha,24-dihydroxyergosterol
Published in Chemistry & biology (01-08-2005)“…We demonstrate the metabolism of ergosterol by cytochrome P450scc in either a reconstituted system or isolated adrenal mitochondria. The major reaction product…”
Get full text
Journal Article